ACHE and Alzheimer disease: Although the current observed changes are of insufficient magnitude to warrant the use of AChE as a reliable diagnostic marker due to the substantial overlap between AD and control samples, we can speculate that an assay which is capable of discriminating between plasma AChE variants of different origins will be useful as a potential biomarker.